Hematology

Immunotherapy

Questions discussed in this category

How do you approach evaluation and management of arthralgia in a patient after CAR-T cell therapy?

1 Answer available

Would you consider antiphospholipid syndrome to be a contraindication for checkpoint inhibitor immunotherapy?

2 Answers available

Is there a role for IL2-receptor antagonists and TNF-alpha inhibitors in cytokine release syndrome as a complication of CAR-T or immunotherapy?

1 Answer available

How early have you been able to detect a response with CAR-T in patients with relapsed DLBCL?

3 Answers available

Papers discussed in this category

The New England journal of medicine, 2017-12-28

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Exp Hematol Oncol, 2021 Feb 19

Etanercept as a new therapeutic option for cytokine release syndrome following chimeric antigen receptor T cell therapy.

Melanoma research, 2017-04

Antiphospholipid syndrome associated with combined immune checkpoint inhibitor therapy.

Lung Cancer, 2021 Aug 03

Antiphospholipid syndrome-induced ischemic stroke following pembrolizumab: Case report and systematic review.

SAGE Open Med Case Rep, 2020 Nov 06

Severe mesenteric ischemia with multiple organ failure in a patient previously treated with a humanized monoclonal antibody against programmed death receptor-1 (pembrolizumab), a case of pembrolizumab associated catastrophic antiphospholipid syndrome?

Related Topics in Hematology